1. Home
  2. HMR vs BMEA Comparison

HMR vs BMEA Comparison

Compare HMR & BMEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HMR

Heidmar Maritime Holdings Corp.

HOLD

Current Price

$1.08

Market Cap

90.3M

ML Signal

HOLD

Logo Biomea Fusion Inc.

BMEA

Biomea Fusion Inc.

HOLD

Current Price

$1.32

Market Cap

95.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HMR
BMEA
Founded
1984
2017
Country
Greece
United States
Employees
52
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
90.3M
95.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
HMR
BMEA
Price
$1.08
$1.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$3.00
$9.83
AVG Volume (30 Days)
133.7K
959.9K
Earning Date
06-09-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
69.19
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$64.04
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.87
52 Week High
$1.71
$2.99

Technical Indicators

Market Signals
Indicator
HMR
BMEA
Relative Strength Index (RSI) 43.70 49.06
Support Level $0.81 $1.23
Resistance Level $1.29 $1.48
Average True Range (ATR) 0.10 0.10
MACD -0.02 0.01
Stochastic Oscillator 22.19 40.91

Price Performance

Historical Comparison
HMR
BMEA

About HMR Heidmar Maritime Holdings Corp.

Heidmar Maritime Holdings Corp is a commercial and technical management company that operates tanker and dry-bulk vessel pools. The group, along with its subsidiaries, operates as a growing tanker pool company engaged in the commercial management and chartering of crude oil and refined petroleum product tankers. Its lines of business currently include asset management, tanker pooling, commercial and time charters, assisting clients with the buying and selling of ships, and technical management services for individual vessels, which include assistance in technical operations and crewing of the vessel. Its geographic areas are Singapore, the USA, the Marshall Islands, the United Arab Emirates, Germany, Switzerland, and Other.

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases. It operate as an organization centered on two of its core drug candidate development programs: (i) icovamenib, its clinical program's drug candidate, currently being developed as an orally bioavailable, and selective, covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity, and (ii) BMF-650, its investigational, next-generation oral glucagon-like peptide-1 GLP-1 receptor agonist in development for the treatment of obesity.

Share on Social Networks: